Company intelligence / Profile preview
SVF Vaccines
Stockholm, Swedensvfvaccines.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
SVF Vaccines develops next-generation vaccines and immunotherapies for life-threatening infectious diseases using proprietary technology from the Karolinska Institute. Its lead candidate, SVF‑002—a universal COVID‑19 DNA vaccine—entered Phase I trials in collaboration with the OpenCorona consortium at Karolinska University Hospital. The company also has preclinical programs targeting chronic hepatitis B/D and Crimean Congo Hemorrhagic Fever. Early clinical data show strong antibody and T-cell responses against SARS-CoV‑2 variants.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DNA vaccinesTherapeutic proteinsProphylactic vaccinesSynthetic peptides
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
Karolinska InstitutetOpenCorona consortium (EU Horizon 2020 funding)phase 1 unit at Karolinska University Hospital
Beyond the preview
Go deeper on SVF Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SVF Vaccines.